Bass, Berry & Sims attorney Jeff Davis authored an article for the American Health Law Association (AHLA) discussing the Health Resources and Services Administration’s (HRSA) approval of a new 340B Rebate Pilot Program. Under the Pilot Program, drug manufacturers will be allowed to offer 340B-discounted drug prices through rebates for ten approved drugs in 2026. … Continued
| less than a minute read
Jeff Davis Discusses HRSA Approval of 340B Drug Rebate Plan

/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-04-06-19-08-21-679-69d404a5924e58bb5dbdb08f.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-04-02-18-54-03-285-69cebb4bc57b3818b9443f78.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-04-01-18-16-41-817-69cd6109167a38b4fab1da8d.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-03-24-20-12-39-840-69c2f0378045f48f34c8b213.jpg)